New Treatments Should Be Introduced Gradually To Avoid Later Problems, Says Expert

Concerns over whether the tests a treatment undergoes before release onto the market are enough to ensure its long-term safety are raised in an editorial published by BMJ Clinical Evidence today. Dr Vijay Sharma suggests that treatments should be introduced gradually so that evidence can be built up and the treatment can find its proper niche. To illustrate this, he discusses the recent debate on the long-term safety of drug-eluting stents. Complete news at...